The use of glycoprotein IIb/ IIIa antagonists in the cardiac catheterization laboratory has continued to increase. These agents, however, have been associated with an increase in both minor and major bleeding complications.1,2 Such...
The use of glycoprotein IIb/ IIIa antagonists in the cardiac catheterization laboratory has continued to increase. These agents, however, have been associated with an increase in both minor and major bleeding complications.1,2 Such...
The use of glycoprotein IIb/...